Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
Conversion from calcineurin-inhibitors (CNIs) to belatacept can help kidney-transplant (KT) recipients avoid CNI-related nephrotoxicity. The risk of associated opportunistic infections (OPIs) is ill-defined. We conducted a multicentric cohort study across 15 French KT-centers in a real-life setting....
Main Authors: | Dominique Bertrand, Florian Terrec, Isabelle Etienne, Nathalie Chavarot, Rebecca Sberro, Philippe Gatault, Cyril Garrouste, Nicolas Bouvier, Anne Grall-Jezequel, Maïté Jaureguy, Sophie Caillard, Eric Thervet, Charlotte Colosio, Leonard Golbin, Jean-Philippe Rerolle, Antoine Thierry, Johnny Sayegh, Bénédicte Janbon, Paolo Malvezzi, Thomas Jouve, Lionel Rostaing, Johan Noble |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/11/3479 |
Similar Items
-
A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection
by: Quentin Perrier, et al.
Published: (2021-01-01) -
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
by: Florian Terrec, et al.
Published: (2021-11-01) -
Belatacept associated - cytomegalovirus retinitis in a kidney transplant recipient: a case report and review of the literature
by: Pierre-Guillaume Deliège, et al.
Published: (2020-12-01) -
Belatacept and mediastinal histoplasmosis in a kidney transplant patient
by: Hernán Trimarchi, et al.
Published: (2016-04-01) -
BELATACEPT IN RENAL TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2013-03-01)